🔎 Trials Near Me

Utama › Kanser Metastatik › Vermont

Kajian klinikal Kanser Metastatik di Vermont

4 kajian untuk Kanser Metastatik sedang mencari peserta di lokasi di Vermont.

Bandar di Vermont

Teks kajian rasmi (Bahasa Inggeris)

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

  • The University of Vermont Medical Center Inc., Burlington
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07174336

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • The University of Vermont Medical Center Inc., Burlington
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT06119581

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

  • University of Vermont Medical Center, Burlington
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT05614739

Hybrid Arc Palliative Radiation Therapy (HART): A Single Arm Phase II Trial

  • University of Vermont Medical Center, Burlington
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Feb 2026 · NCT06778408

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.